Publicaciones en las que colabora con Enrique José Andreu Oltra (39)

2023

  1. Enhanced bioprocess control to advance the manufacture of mesenchymal stromal cell-derived extracellular vesicles in stirred-tank bioreactors

    Biotechnology and Bioengineering, Vol. 120, Núm. 9, pp. 2725-2741

2022

  1. Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome

    Frontiers in Immunology, Vol. 13

2021

  1. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

2020

  1. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study

    EClinicalMedicine, Vol. 25

  2. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  3. Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis

    Journal of Translational Medicine, Vol. 18, Núm. 1

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

2018

  1. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: Long-term follow up of a multicenter randomized controlled clinical trial (phase I/II)

    Journal of Translational Medicine

2017

  1. Combined PI3K/Akt and Smad2 activation promotes corneal endothelial cell proliferation

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 745-754

  2. Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells

    Translational Research, Vol. 188, pp. 80-91.e2

2016

  1. Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue

    Stem Cell Research, Vol. 16, Núm. 1, pp. 20-23

  2. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: Multicenter randomized controlled clinical trial (phase I/II)

    Journal of Translational Medicine, Vol. 14, Núm. 1

2015

  1. Efficacy of autologous melanocyte transplantation on amniotic membrane in patientswith stable leukoderma: A randomized clinical trial

    JAMA Dermatology

2014

  1. Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy

    International Journal of Ophthalmology, Vol. 7, Núm. 6, pp. 988-995

  2. Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease

    Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 10, pp. 1580-1585

2013

  1. Culture of human bone marrow-derived mesenchymal stem cells on of poly(l-lactic acid) scaffolds: Potential application for the tissue engineering of cartilage

    Knee Surgery, Sports Traumatology, Arthroscopy, Vol. 21, Núm. 8, pp. 1737-1750

2011

  1. Amniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo

    Dermatology Research and Practice, Vol. 2011

  2. MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia

    Cell Transplantation, Vol. 20, Núm. 2, pp. 259-269

  3. Mechanical properties of cross-linked collagen meshes after human adipose derived stromal cells seeding

    Journal of Biomedical Materials Research - Part A, Vol. 96 A, Núm. 2, pp. 341-348

2010

  1. Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and-resistant Bcr-Abl1-expressing cells

    Oncogene, Vol. 29, Núm. 22, pp. 3276-3286